共 10 条
[1]
Metabolic Syndrome and Risk of Acute Myocardial Infarction[J] . Andrew Mente,Salim Yusuf,Shofiqul Islam,Matthew J. McQueen,Supachai Tanomsup,Churchill L. Onen,Sumathy Rangarajan,Hertzel C. Gerstein,Sonia S. Anand. Journal of the American College of Cardiology . 2010 (21)
[2]
Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia: Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women From Primary Prevention Trials[J] . Samia Mora,Robert J. Glynn,Judith Hsia,Jean G. MacFadyen,Jacques Genest,Paul M. Ridker. Circulation . 2010 (9)
[3]
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial[J] . GISSI-HF investigators. The Lancet . 2008 (9645)
[4]
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis[J] . Cholesterol Treatment Trialists’ (CTT) Collaborators. The Lancet . 2008 (9607)
[5]
Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention[J] . Giuseppe Patti,Vincenzo Pasceri,Giuseppe Colonna,Marco Miglionico,Dionigi Fischetti,Gennaro Sardella,Antonio Montinaro,Germano Di Sciascio. Journal of the American College of Cardiology . 2007 (12)
[6]
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial[J] . Helen M Colhoun,D John Betteridge,Paul N Durrington,Graham A Hitman,H Andrew W Neil,Shona J Livingstone,Margaret J Thomason,Michael I Mackness,Valentine Charlton-Menys,John H Fuller. The Lancet . 2004 (9435)
[7]
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial[J] . The Lancet . 2003 (9364)
[8]
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial[J] . The Lancet . 2002 (9326)
[9]
Statin administration before percutaneous coronary intervention:impact on periprocedural myocardial infarction .2 Briguori C,Colombob A,Airoldi E,et al. Eur Heart J . 2004
[10]
Effect of two intensivestatinregimensonprogressionofcoronarydisease .2 Nicholls SJ,Ballantyne CM,Barter PJ,et al. NEnglJMed . 2011